HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

2,2'-dipyridylamine

Also Known As:

bis(2-pyridyl)amine; di(alpha-pyridyl)amine; 2-Pyridinamine, N-2-pyridinyl-

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - 2,2'-Dipyridyl: 132
      - 2,2'-dipyridylamine: 3

Experts

1.	Trávníček, Zdeněk: 2 articles (04/2018 - 11/2012)
2.	Dvořák, Zdeněk: 1 article (04/2018)
3.	Herchel, Radovan: 1 article (04/2018)
4.	Jewula, Pawel: 1 article (04/2018)
5.	Štarha, Pavel: 1 article (04/2018)
6.	Hey-Hawkins, Evamarie: 1 article (12/2015)
7.	Kaluđerović, Goran N: 1 article (12/2015)
8.	Krajnović, Tamara: 1 article (12/2015)
9.	Maksimović-Ivanić, Danijela: 1 article (12/2015)
10.	Mijatović, Sanja: 1 article (12/2015)

Related Diseases

1.	Osteosarcoma (Osteogenic Sarcoma) 11/01/2012 - "Six mixed-ligand copper(II) complexes with the composition [Cu(qui)(L)]BF(4)·xH(2)O (1-6), where Hqui=2-phenyl-3-hydroxy-4(1H)-quinolinone, L=2,2'-bipyridine (bpy) (1), 1,10-phenanthroline (phen) (2), bis(2-pyridyl)amine (ambpy) (3), 5-methyl-1,10-phenanthroline (mphen) (4), 5-nitro-1,10-phenanthroline (nphen) (5) and bathophenanthroline (bphen) (6), were prepared, fully characterized and studied for their in vitro cytotoxicity on human osteosarcoma (HOS) and human breast adenocarcinoma (MCF7) cancer cell lines. "
2.	Neoplasms (Cancer) 11/01/2012 - "Six mixed-ligand copper(II) complexes with the composition [Cu(qui)(L)]BF(4)·xH(2)O (1-6), where Hqui=2-phenyl-3-hydroxy-4(1H)-quinolinone, L=2,2'-bipyridine (bpy) (1), 1,10-phenanthroline (phen) (2), bis(2-pyridyl)amine (ambpy) (3), 5-methyl-1,10-phenanthroline (mphen) (4), 5-nitro-1,10-phenanthroline (nphen) (5) and bathophenanthroline (bphen) (6), were prepared, fully characterized and studied for their in vitro cytotoxicity on human osteosarcoma (HOS) and human breast adenocarcinoma (MCF7) cancer cell lines. "
3.	Carcinoma (Carcinomatosis) 04/24/2018 - "The [Os(η6-pcym)(dpa)(VP)]PF6 (1-VP) complex contains the histone deacetylase (HDAC) inhibitor valproate (2-propylpentanoate; VP) as a monodentate O-donor ligand and shows ca. 3-fold higher in vitro cytotoxicity against A2780 human ovarian carcinoma cells than its chlorido analogue [Os(η6-pcym)(dpa)Cl]PF6 (1-Cl); pcym = 1-methyl-4-(propan-2-yl)benzene (p-cymene), dpa = 2,2'-dipyridylamine. "
4.	Breast Neoplasms (Breast Cancer) 12/01/2015 - "Ruthenium(II) p-cymene complex bearing 2,2'-dipyridylamine targets caspase 3 deficient MCF-7 breast cancer cells without disruption of antitumor immune response."
5.	Adenocarcinoma 11/01/2012 - "Six mixed-ligand copper(II) complexes with the composition [Cu(qui)(L)]BF(4)·xH(2)O (1-6), where Hqui=2-phenyl-3-hydroxy-4(1H)-quinolinone, L=2,2'-bipyridine (bpy) (1), 1,10-phenanthroline (phen) (2), bis(2-pyridyl)amine (ambpy) (3), 5-methyl-1,10-phenanthroline (mphen) (4), 5-nitro-1,10-phenanthroline (nphen) (5) and bathophenanthroline (bphen) (6), were prepared, fully characterized and studied for their in vitro cytotoxicity on human osteosarcoma (HOS) and human breast adenocarcinoma (MCF7) cancer cell lines. "

Related Drugs and Biologics

1.	Ligands
2.	4-cymene (p-cymene)
3.	Histone Deacetylase Inhibitors
4.	Caspase 3 (Caspase-3)
5.	Quinolones
6.	2,2'-Dipyridyl (2,2 Bipyridine)
7.	Valproic Acid (Depakote)
8.	Ruthenium
9.	Histone Deacetylases (Histone Deacetylase)
10.	Copper